Titles: H.R.269 — 116th Congress (2019-2020)All Information (Except Text)

Short Titles

Short Titles - House of Representatives

Short Titles as Passed House

Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

Short Titles as Passed House for portions of this bill
  • Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
  • Over-the-Counter Monograph User Fee Act of 2019

Short Titles as Introduced

Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

Short Titles as Introduced for portions of this bill
  • Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
  • Over-the-Counter Monograph User Fee Act of 2019

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.